FI885055A0 - Celltillvaext inhiberande faktor. - Google Patents

Celltillvaext inhiberande faktor.

Info

Publication number
FI885055A0
FI885055A0 FI885055A FI885055A FI885055A0 FI 885055 A0 FI885055 A0 FI 885055A0 FI 885055 A FI885055 A FI 885055A FI 885055 A FI885055 A FI 885055A FI 885055 A0 FI885055 A0 FI 885055A0
Authority
FI
Finland
Prior art keywords
inhiberande
celltillvaext
factor
inhiberande factor
celltillvaext inhiberande
Prior art date
Application number
FI885055A
Other languages
English (en)
Other versions
FI885055A (fi
Inventor
John M Rowe
Mohammed Shoyab
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of FI885055A0 publication Critical patent/FI885055A0/fi
Publication of FI885055A publication Critical patent/FI885055A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI885055A 1987-11-06 1988-11-02 Celltillvaext inhiberande faktor. FI885055A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11818587A 1987-11-06 1987-11-06

Publications (2)

Publication Number Publication Date
FI885055A0 true FI885055A0 (fi) 1988-11-02
FI885055A FI885055A (fi) 1989-05-07

Family

ID=22377016

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885055A FI885055A (fi) 1987-11-06 1988-11-02 Celltillvaext inhiberande faktor.

Country Status (12)

Country Link
EP (1) EP0315289A3 (fi)
JP (1) JPH0272869A (fi)
KR (1) KR910002520B1 (fi)
CN (1) CN1040926A (fi)
AU (1) AU629185B2 (fi)
DK (1) DK618188A (fi)
FI (1) FI885055A (fi)
IL (1) IL88276A (fi)
NO (1) NO884943L (fi)
NZ (1) NZ226799A (fi)
PT (1) PT88943A (fi)
ZA (1) ZA888269B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352743A (en) * 1990-01-16 1994-10-04 Mobil Oil Corporation Solid elastomeric block copolymers
US5916871A (en) * 1992-04-27 1999-06-29 Kansas State University Research Foundation Inhibitory factor
CA2134443A1 (en) * 1992-04-27 1993-11-11 Terry C. Johnson Inhibitory factor
WO2000055319A1 (en) * 1999-03-12 2000-09-21 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
WO1997037017A1 (fr) * 1996-03-29 1997-10-09 JAPAN, represented by DIRECTOR GENERAL OF NATIONAL INSTITUTE OF HEALTH SCIENCES Facteurs cytostatiques
WO2000032778A2 (en) * 1998-12-01 2000-06-08 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
WO2000053751A1 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
EP1121439B1 (en) * 1998-10-13 2006-07-12 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
IL143031A0 (en) * 1998-12-22 2002-04-21 Genentech Inc Methods and compositions for inhibiting neoplastic cell growth
EP1484338B1 (en) * 1998-12-22 2007-02-07 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
AU3246100A (en) * 1999-06-02 2000-12-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
AU2215300A (en) * 1999-06-02 2000-12-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
DK1185648T3 (da) * 1999-06-02 2007-07-30 Genentech Inc Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst
EP1867719A3 (en) * 1999-06-02 2008-03-19 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
EP1244784A2 (en) * 2000-01-06 2002-10-02 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816440A (en) * 1985-09-26 1989-03-28 Cetus Corporation Stable formulation of biologically active proteins for parenteral injection
EP0536520B1 (en) * 1985-10-14 1999-03-03 Yeda Research And Development Co. Ltd. Use of Human Interferon-Beta 2A for the preparation of medicaments
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0585957A1 (en) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies

Also Published As

Publication number Publication date
PT88943A (pt) 1989-11-30
KR890007751A (ko) 1989-07-05
ZA888269B (en) 1989-07-26
FI885055A (fi) 1989-05-07
JPH0272869A (ja) 1990-03-13
EP0315289A2 (en) 1989-05-10
AU629185B2 (en) 1992-10-01
AU2474088A (en) 1989-05-11
KR910002520B1 (ko) 1991-04-23
EP0315289A3 (en) 1990-04-11
DK618188D0 (da) 1988-11-04
NO884943L (no) 1989-05-08
DK618188A (da) 1989-05-07
NO884943D0 (no) 1988-11-04
IL88276A (en) 1993-08-18
IL88276A0 (en) 1989-06-30
NZ226799A (en) 1991-08-27
CN1040926A (zh) 1990-04-04

Similar Documents

Publication Publication Date Title
NO885339D0 (no) Leukemi-inhiberende faktor.
DE3880632D1 (de) Kuevette.
DE3881291D1 (de) Sehapparat.
DE3862564D1 (de) Erdanker.
FI913251A0 (fi) Renad kiliarisk neurotrofisk faktor.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
DE3883705D1 (de) Alkenylbicyclohexane.
DE3876873T2 (de) Weblitzenuebergabevorrichtung.
DE3785663D1 (de) Loetgeraet.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3882446T2 (de) Polydisilacyclobutasilazane.
FI880020A0 (fi) Vaesentigen ren cytotoxitet utloesande faktor.
FI885055A0 (fi) Celltillvaext inhiberande faktor.
DE3870513D1 (de) Tennisball.
FI893474A0 (fi) Neutrofiler aktiverande faktor.
DE3888991D1 (de) Aminokohlenwasserstoff-substituierte Ketoximosilane.
DE3877421T2 (de) Polyamidbenzazole.
DE3879348T2 (de) Fm-cw-radargeraet.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
DE3878970D1 (de) Praeparative chromatographiesaeule.
DE3861694D1 (de) Cyclopropancarboxamide.
DE3853279T2 (de) Laryngoskop.
DE3860307D1 (de) 2-aminomethyltetrahydrofurane.
DE3860710D1 (de) Exklusiv-oder-schaltung.
NO882745D0 (no) Kolecystokininderivater.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: ONCOGEN